Viewing Study NCT05075213


Ignite Creation Date: 2025-12-18 @ 9:42 AM
Ignite Modification Date: 2025-12-23 @ 10:30 PM
Study NCT ID: NCT05075213
Status: None
Last Update Posted: 2024-08-15 00:00:00
First Post: 2021-09-17 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: QuitBet Phase II: A Digital Social Game That Pays You to Stop Smoking
Sponsor: None
Organization:

Study Overview

Official Title: QuitBet Phase II: A Digital Social Game That Pays You to Stop Smoking
Status: None
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study is a randomized controlled trial (RCT) of QuitBet, a digital contingency management program for smoking cessation. QuitBet combines social gaming elements with participant-funded financial incentives in the form of a deposit contract. QuitBet "players" deposit (called the "bet") a specified amount of their own money into the game's "pot." All "winners" who achieve the game's goal split the pot equally, such that their bet is fully refunded plus they receive extra money from the forfeited bets of players who did not meet the goal. Participants (N = 550) will be randomly assigned to QuitBet or QuitBet-NS (deposit contract only, no social elements). All participants will be offered a second game after their first game (up to 8 weeks total game duration) and will be asked to complete a survey after each game and at 1 and 4 months after the end of the second game (3 and 6 months after the start of their first game). The study will compare QuitBet vs. QuitBet-NS on smoking behavior outcomes and examine potential mediators of outcomes such as motivation, engagement, and satisfaction.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: